|

ADI-PEG 20 Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Pegargiminase

Pipeline

Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • M.D. Anderson Cancer Center1
  • Global Coalition for Adaptive Research1

Indications

  • Cancer2
  • Glioblastoma1
  • Prostate Cancer1

Birmingham, Alabama1 trial

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

University of Alabama at Birmingham

Phase 2/3

Houston, Texas1 trial

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.